MMP-9 inhibitor (Janssen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMMP-9 inhibitor (Janssen)
Drug Alias Namematrix metalloproteinase 9 inhibitor (J&J)matrix metalloproteinase 9 inhibitor (Janssen)MMP-9 inhibitor (J&J)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 9 inhibitors
TargetsMatrix metalloproteinase 9
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, MajorBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A